A Pilot Study to Evaluate the Safety and Efficacy of the Long-acting IL-1 Inhibitor, Rilonacept (IL-1 Trap) in Patients with Familial Cold Autoinflammatory Syndrome (FCAS)

OBJECTIVE: Familial cold autoinflammatory syndrome (FCAS) is caused by mutations in CIAS1 leading to excessive secretion of IL-1β, which is associated with cold induced fevers, joint pain and systemic inflammation. This pilot study was conducted to assess the safety and efficacy of the long acting I...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Goldbach-Mansky, Raphaela, Shroff, Sharukh, Wilson, Mildred, Snyder, Christopher, Plehn, Sara, Barham, Beverly, Pham, Tuyet Hang, Kastner, Daniel L., Pucino, Frank, Wesley, Robert A., Papadopoulos, Joanne, Weinstein, Steven, Mellis, Scott
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2008
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875198/
https://ncbi.nlm.nih.gov/pubmed/18668591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.23620
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi